MYCN and neuroblastoma: To evaluate the effect of HCI-2509 on various poorly differentiated neuroblastoma cell lines, we studied cell lines that are MYCN amplified (LAN5 and NGP) and non-MYCN-amplified (SH-SY5Y and SK-N-SH).